Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RITUXIMAB-PVVR vs RIZATRIPTAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RITUXIMAB-PVVR vs RIZATRIPTAN: Safety Overview

Metric RITUXIMAB-PVVR RIZATRIPTAN
Total FAERS Reports 4,210 2,896
Deaths Reported 415 68
Death Rate 9.9% 2.3%
Hospitalizations 966 479
Average Patient Age 60.4 yrs 44.6 yrs
% Female Patients 67.9% 77.2%
FDA Approval Date N/A Apr 14, 2023
Manufacturer N/A Panacea Biotec Limited
Route N/A ORAL
Marketing Status Prescription Discontinued